
As knee osteoarthritis continues to affect aging populations worldwide, a new minimally invasive procedure known as Genicular Artery Embolization (GAE) is emerging as a promising alternative for patients suffering from chronic knee pain who wish to avoid major surgery.
The technique has gained increasing international attention, particularly in the United States and Japan, where it is being adopted as part of a broader movement toward image-guided, minimally invasive therapies designed to reduce recovery time while targeting the underlying mechanisms of disease.
Knee osteoarthritis is one of the most common causes of chronic pain among older adults and is closely associated with aging, obesity, repetitive joint stress, previous injury, and inflammatory joint disease. Conventional treatment usually begins with pain medication, physical therapy, lifestyle modification, or intra-articular injections such as steroids or hyaluronic acid. However, many patients continue to experience persistent pain despite these interventions, while others are reluctant to undergo total knee replacement surgery because of recovery time, surgical risk, or underlying medical conditions.
According to Dr. Noppachai Siranart, Postdoctoral Research Fellow at Brigham and Women’s Hospital / Harvard Medical School and founder of YOUNIFY Clinic, a healthy aging and wellness center specializing in weight management and non-surgical knee pain treatment, GAE is helping bridge an important treatment gap between conservative therapy and joint replacement surgery.
“Many patients live with chronic knee pain for years despite multiple treatments,” Dr. Noppachai explained. “GAE offers a less-invasive option that directly targets the abnormal inflammatory blood vessels believed to contribute to persistent pain in knee osteoarthritis.”
The concept behind GAE is based on growing evidence that chronic inflammation inside the knee joint stimulates the formation of abnormal blood vessels and nerve growth around the inflamed synovial tissue. These changes contribute to ongoing pain and perpetuate a cycle of inflammation.
During the procedure, physicians use image-guided catheter techniques to selectively block these abnormal blood vessels using microscopic embolic particles, thereby reducing inflammatory activity and interrupting the pain cycle.
Unlike traditional orthopedic surgery, GAE does not involve cutting bone or replacing the joint. The procedure is performed through a tiny pinhole-sized catheter inserted through the groin under local anesthesia and mild sedation.
Using real-time angiographic imaging, an interventional radiologist navigates the catheter to the abnormal vessels surrounding the knee and delivers embolic material precisely to the inflamed areas. The procedure typically takes one to two hours, and most patients are discharged on the same day after several hours of observation.
Because the treatment targets only the small abnormal vessels associated with inflammation while preserving normal blood flow to the knee, the risk of damage to surrounding tissue is considered low.
One of the key advantages of GAE is its minimal recovery time compared with conventional knee replacement surgery. Most patients are able to resume normal daily activities within one to two weeks, with only mild discomfort during the first few days after treatment.
The procedure is generally considered suitable for patients with chronic knee pain from osteoarthritis who have failed conservative treatment, including pain medication, physical therapy, or steroid injections, as well as individuals seeking to delay or avoid joint replacement surgery altogether.
Current international data suggest that pain relief following GAE may last several years in appropriately selected patients, and the procedure can potentially be repeated if symptoms recur.
As medicine increasingly shifts toward precision-based and minimally invasive treatment strategies, GAE is being recognized as one of the emerging technologies redefining musculoskeletal care.
Rather than focusing solely on symptom suppression, the procedure aims to address the inflammatory vascular changes believed to drive chronic pain in osteoarthritis. Experts believe this targeted approach may represent an important evolution in the management of degenerative joint disease — especially for patients seeking effective pain relief without major surgery.
With growing clinical experience and expanding global adoption, GAE is expected to become an increasingly important option in the future landscape of osteoarthritis treatment.
Noppachai Siranart, M.D.
Founder at Younify Clinic
https://www.younifyclinic.com/
Reference
YOUNIFY Clinic. Knee osteoarthritis treatment [Internet]. Bangkok: YOUNIFY Clinic; [cited 2026 Jun 8]. Available from: https://www.younifyclinic.com/en/services/knee